Core Viewpoint - Hongxiang Co., Ltd. has been found guilty of false statements leading to investor claims, with a precedent for winning such cases already established [1][5]. Information Disclosure Violations - From 2017 to 2022, Hongxiang Co., Ltd. and its subsidiary fabricated sales, procurement, and inflated fixed assets, resulting in significant financial misstatements: - In 2017, inflated revenue by 104.89 million and profit by 59.72 million, representing 14.10% and 38.03% of disclosed amounts respectively [5]. - In 2018, inflated revenue by 255.59 million and profit by 144.22 million, representing 19.49% and 47.72% of disclosed amounts respectively [5]. - In 2019, inflated revenue by 227.07 million and profit by 141.18 million, representing 16.94% and 48.19% of disclosed amounts respectively [5]. - In 2020, inflated revenue by 304.97 million and profit by 75.38 million, representing 20.12% and 29.79% of disclosed amounts respectively [5]. - In 2021, inflated revenue by 108.80 million and reduced profit by 3.25 million, representing 7.80% and 0.51% of disclosed amounts respectively [5]. - In 2022, inflated costs by 24.88 million and reduced profit by 24.88 million, representing 2.15% and 33.27% of disclosed amounts respectively [5]. Fraudulent Issuance - The non-public offering of shares in 2019 constituted fraudulent issuance [6]. - The public offering of convertible bonds in 2020 also constituted fraudulent issuance [7]. - The 2020 application for issuing shares and cash purchases of assets contained significant false statements [8]. Investor Claims - Investors who purchased Hongxiang Co., Ltd. shares between March 30, 2018, and April 29, 2023, and sold or held shares after April 29, 2023, are eligible to initiate claims [9].
红相股份(300427)投资者索赔已有胜诉先例,索赔倒计时